Comparative efficacy of indacaterol in chronic obstructive pulmonary disease Full Text
International Journal of COPD,  Clinical Article

Ribeiro M et al. – Data from trials with the novel once–daily β2–agonist, indacaterol, indicate superior bronchodilation and clinical efficacy over twice–daily long–acting β2–agonists and at least equipotent bronchodilation as once–daily tiotropium. Bronchodilators are central in the symptomatic management of chronic obstructive pulmonary disease (COPD). It is likely that once–daily dosing of a bronchodilator would be a significant convenience and probably a compliance–enhancing advantage, leading to improved overall clinical outcomes in patients with COPD.

  • Long–acting bronchodilators have been shown to improve multiple clinical outcomes in chronic obstructive pulmonary disease (COPD) including lung function, symptoms, dyspnea, quality of life, and exacerbations.
  • Indacaterol is a novel, inhaled, long–acting β2–agonist providing 24–hour bronchodilation with once–daily dosing.
  • It is currently approved for the maintenance treatment of COPD to be administered as 150 or 300 µg once–daily doses as licensed in many countries and 75 µg as licensed in the US by means of a single–dose dry powder inhaler.
  • The data from clinical development support a favorable safety and tolerability profile within the β2–agonist drug class, with no relevant issues identified.
  • Current evidence indicates that indacaterol is suitable for use as first–line monotherapy in COPD patients with moderate disease (Global Initiative for Chronic Obstructive Lung Disease [GOLD] stage II) and beyond that do not require an inhaled corticosteroid (ICS) as per GOLD guidelines, or in combination with an ICS in severe or very severe patients with repeated exacerbations.

Please login or register to follow this author.
► Click here to access Full Text, PubMed, Publisher and related articles...
<< Previous Article | Next Article >>

Your Unread Messages in Pulmonology

See All >> Messages include industry-sponsored communications and special communications from MDLinx

Most Popular Pulmonology Articles

1 Cytotoxic agents in sarcoidosis: Which one should we choose? Current Opinion in Pulmonary Medicine, August 15, 2014    Review Article

2 Microfibrillar-associated protein 4: A potential biomarker of chronic obstructive pulmonary disease Respiratory Medicine, September 19, 2014    Clinical Article

3 Efficacy of azithromycin in the treatment of bronchiectasis Respirology, September 9, 2014    Clinical Article

4 Prevalence of chronic obstructive pulmonary disease among US working adults aged 40 to 70 years: National Health Interview Survey data 2004 to 2011 Journal of Occupational and Environmental Medicine, October 17, 2014    Clinical Article

5 Efficacy of mycophenolate mofetil in sarcoidosis Respiratory Medicine, October 29, 2014    Review Article

6 The effects of high intensity exercise during pulmonary rehabilitation on ventilatory parameters in people with moderate to severe stable COPD: A systematic review Full Text International Journal of COPD, October 14, 2014    Free full text    Evidence Based Medicine    Clinical Article

7 Efficacy and safety of a fixed-dose combination of indacaterol and glycopyrronium for the treatment of COPD: A systematic review Chest, August 21, 2014    Evidence Based Medicine

8 Comparing the effectiveness of small-particle versus large-particle inhaled corticosteroid in COPD Full Text International Journal of COPD, October 24, 2014    Free full text    Clinical Article

9 Predictors of physical inactivity in elderly patients with chronic obstructive pulmonary disease Full Text International Journal of Gerontology, September 25, 2014    Free full text    Clinical Article

10 Prophylactic antibiotic therapy after inhalation injury Burns, October 10, 2014    Clinical Article

11 Withdrawal of inhaled glucocorticoids and exacerbations of COPD New England Journal of Medicine, September 12, 2014    Evidence Based Medicine    Clinical Article

12 Endobronchial ultrasound-guided transbronchial needle aspiration vs conventional transbronchial needle aspiration in the diagnosis of sarcoidosis Chest, September 9, 2014    Clinical Article

13 The clinical features of sarcoidosis: a comprehensive review Clinical Reviews in Allergy and Immunology, October 10, 2014    Clinical Article

14 Comparison of US emergency department acute asthma care quality: 1997-2001 and 2001-2012 The Journal of Allergy and Clinical Immunology, October 7, 2014    Clinical Article

15 Azithromycin maintenance treatment in patients with frequent exacerbations of chronic obstructive pulmonary disease (COLUMBUS): A randomised, double-blind, placebo-controlled trial The Lancet Respiratory Medicine, May 15, 2014    Clinical Article

16 Benefits of an oxygen reservoir cannula versus a conventional nasal cannula during exercise in hypoxemic COPD patients: A crossover trial Respiration, October 21, 2014    Clinical Article

17 Does the 2013 GOLD classification improve the ability to predict lung function decline, exacerbations and mortality: A post-hoc analysis of the 4-year UPLIFT trial Full Text BMC Pulmonary Medicine, October 22, 2014    Free full text    Clinical Article

18 Pulmonary artery size as a predictor of pulmonary hypertension and outcomes in patients with chronic obstructive pulmonary disease Respiratory Medicine, October 3, 2014    Clinical Article

19 The use of N-acetylcysteine in respiratory diseases Current Respiratory Medicine Reviews, July 17, 2014    Review Article

20 Cold spells and the risk of hospitalization for asthma: New York, USA 1991–2006 Lung, October 15, 2014    Clinical Article

Indexed Journals in Pulmonology: Chest, Thorax, American Journal of Respiratory and Critical Care Medicinemore